The Target Concentration Approach to Clinical Drug Development
- 1 November 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 29 (5), 287-291
- https://doi.org/10.2165/00003088-199529050-00001
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Population pharmacodynamics of romazarit.British Journal of Clinical Pharmacology, 1995
- Comparative efficiencies of randomized concentration- and dose-controlled clinical trialsClinical Pharmacology & Therapeutics, 1994
- Concentration- or effect-controlled clinical trials with sparse dataClinical Pharmacology & Therapeutics, 1994
- Theophylline Target Concentration in Severe Airways Obstruction - 10 or 20 mg/L?Clinical Pharmacokinetics, 1993
- Time and Theophylline Concentration Help Explain the Recovery of Peak Flow Following Acute Airways ObstructionClinical Pharmacokinetics, 1993
- Concentration-controlled versus concentration-defined clinical trialsClinical Pharmacology & Therapeutics, 1993
- Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug developmentClinical Pharmacology & Therapeutics, 1992
- The intellectual health of clinical drug evaluationClinical Pharmacology & Therapeutics, 1991
- Pharmacologically Guided Phase I Clinical Trials Based Upon Preclinical Drug DevelopmentJNCI Journal of the National Cancer Institute, 1990
- THEOPHYLLINE SERUM CONCENTRATION AND THERAPEUTIC EFFECT IN SEVERE ACUTE BRONCHIAL OBSTRUCTION - THE OPTIMAL USE OF INTRAVENOUSLY ADMINISTERED AMINOPHYLLINEPublished by Elsevier BV ,1982